Document is current
Any future updates will be listed below
-
Authors
Probst, Alexandra S. https://orcid.org/0000-0001-8389-8159
Paton, Douglas G.
Appetecchia, Federico
Bopp, Selina https://orcid.org/0000-0002-9412-9766
Adams, Kelsey L. https://orcid.org/0000-0002-1184-8360
Rinvee, Tasneem A.
Pou, Sovitj
Winter, Rolf
Du, Esrah W.
Yahiya, Sabrina https://orcid.org/0000-0003-1600-6186
Vidoudez, Charles https://orcid.org/0000-0003-0953-7800
Singh, Naresh
Rodrigues, Janneth https://orcid.org/0000-0001-9693-1958
Castañeda-Casado, Pablo
Tammaro, Chiara https://orcid.org/0000-0003-1748-2512
Chen, Daisy https://orcid.org/0000-0001-6516-7029
Godinez-Macias, Karla P.
Jaramillo, Jasmine L.
Poce, Giovanna https://orcid.org/0000-0001-7466-8861
Rubal, Michael J.
Nilsen, Aaron
Winzeler, Elizabeth A.
Baum, Jake https://orcid.org/0000-0002-0275-352X
Burrows, Jeremy N. https://orcid.org/0000-0001-8448-6068
Riscoe, Michael K. https://orcid.org/0000-0002-1343-5279
Wirth, Dyann F. https://orcid.org/0000-0002-8604-4455
Catteruccia, Flaminia https://orcid.org/0000-0003-3295-6683
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 17 April 2025
First Online: 21 May 2025
Competing interests
: D.G.P. and F.C. hold a patent on the use of mosquito contact with antimalarials to reduce Plasmodium transmission (patent number WO2020051130A1). M.K.R., A.N., D.G.P. and F.C. have submitted a patent application (provisional patent application number 63/651,852) on the use of ELQ prodrugs deposited on surfaces for mosquito-targeted malaria-transmission blocking. The other authors declare no competing interests.
